Literature DB >> 7683038

Identification of two cytotoxic T lymphocyte-recognized epitopes in the Ras protein.

J Skipper1, H J Stauss.   

Abstract

We have investigated the possibility of inducing cytotoxic T lymphocytes (CTL) to Ras containing a mutation at position 61 or to normal Ras, using recombinant vaccinia viruses expressing these proteins. CTL from C57Bl/10 mice immunized with vaccinia expressing mutant Ras showed specificity for the mutant Ras protein and recognition of normal Ras was inefficient. The opposite specificity was observed after immunization with vaccinia expressing normal Ras, since CTL isolated from these mice recognized normal Ras well and mutant Ras inefficiently. Levels of endogenous Ras expression were insufficient for lysis by these CTL. One CTL epitope mapped to amino acids 60-67 and residue 61 was critical for T cell recognition. CTL generated against mutant Ras protein recognized peptide 60-67 containing mutant residue 61, while anti-normal Ras CTL recognized the wild-type 60-67 sequence. A second epitope mapped to residues 152-159 of Ras and was recognized equally well by CTL raised to normal or mutant Ras. The murine data raise the possibility of exploiting Ras-specific CTL for targeted immunotherapy of certain human cancers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683038      PMCID: PMC2190995          DOI: 10.1084/jem.177.5.1493

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

Review 1.  A molecular model of MHC class-I-restricted antigen processing.

Authors:  J J Monaco
Journal:  Immunol Today       Date:  1992-05

2.  Localization of allodeterminants on H-2Kb antigens determined with monoclonal antibodies and H-2 mutant mice.

Authors:  G J Hämmerling; E Rüsch; N Tada; S Kimura; U Hämmerling
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

3.  Mechanism of activation of a human oncogene.

Authors:  C J Tabin; S M Bradley; C I Bargmann; R A Weinberg; A G Papageorge; E M Scolnick; R Dhar; D R Lowy; E H Chang
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

4.  Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.

Authors:  D P Dialynas; Z S Quan; K A Wall; A Pierres; J Quintáns; M R Loken; M Pierres; F W Fitch
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

5.  Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations.

Authors:  D J Capon; P H Seeburg; J P McGrath; J S Hayflick; U Edman; A D Levinson; D V Goeddel
Journal:  Nature       Date:  1983 Aug 11-17       Impact factor: 49.962

6.  Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change.

Authors:  E Taparowsky; Y Suard; O Fasano; K Shimizu; M Goldfarb; M Wigler
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

7.  T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides.

Authors:  T Gedde-Dahl; J A Eriksen; E Thorsby; G Gaudernack
Journal:  Hum Immunol       Date:  1992-04       Impact factor: 2.850

8.  Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus.

Authors:  E H Chang; M E Furth; E M Scolnick; D R Lowy
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

9.  Memory T cells of a patient with follicular thyroid carcinoma recognize peptides derived from mutated p21 ras (Gln-->Leu61).

Authors:  T Gedde-Dahl; A Spurkland; J A Eriksen; E Thorsby; G Gaudernack
Journal:  Int Immunol       Date:  1992-11       Impact factor: 4.823

10.  Studies in antibody response of mice to tumour inoculation.

Authors:  P A GORER
Journal:  Br J Cancer       Date:  1950-12       Impact factor: 7.640

View more
  22 in total

Review 1.  Cancer gene and immunotherapy: recent developments.

Authors:  P Jantscheff; R Herrmann; C Rochlitz
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

2.  38 000 MW antigen-specific major histocompatibility complex class I restricted interferon-gamma-secreting CD8+ T cells in healthy contacts of tuberculosis.

Authors:  R J Wilkinson; X Zhu; K A Wilkinson; A Lalvani; J Ivanyi; G Pasvol; H M Vordermeier
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

Review 3.  Immunotherapy II: Antigens, receptors and costimulation.

Authors:  P F Searle; L S Young
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 4.  Direct identification of tumor-associated peptide antigens.

Authors:  V H Engelhard
Journal:  Springer Semin Immunopathol       Date:  1996

5.  Gene therapy in gastroenterology.

Authors:  H S Pandha; N R Lemoine
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

6.  Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigen.

Authors:  M Wang; P W Chen; V Bronte; S A Rosenberg; N P Restifo
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1995-10

7.  Vaccination with recombinant vaccinia viruses protects mice against Mycobacterium tuberculosis infection.

Authors:  X Zhu; N Venkataprasad; J Ivanyi; H M Vordermeier
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

8.  Induction in transgenic mice of HLA-A2.1-restricted cytotoxic T cells specific for a peptide sequence from a mutated p21ras protein.

Authors:  P Escobar; Z Yu; A Terskikh; N Holmes; G Corradin; J P Mach; F Healy
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

9.  Growth inhibition of a colonic adenocarcinoma cell line (HT29) by T cells specific for mutant p21 ras.

Authors:  T Gedde-Dahl; E Nilsen; E Thorsby; G Gaudernack
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

10.  CD8+ T cells from a patient with colon carcinoma, specific for a mutant p21-Ras-derived peptide (Gly13-->Asp), are cytotoxic towards a carcinoma cell line harbouring the same mutation.

Authors:  B Fossum; A C Olsen; E Thorsby; G Gaudernack
Journal:  Cancer Immunol Immunother       Date:  1995-03       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.